Limited coverage drugs – ipratropium and salbutamol combination nebules

Strength & form

ipratropium 0.5 mg in combination with salbutamol 2.5 mg per 2.5 mL unit dose vial

nebule for inhalation

Person has cognitive impairment
PLUS
has had an unsuccessful trial in the use of an inhaler attached to an aerochamber with a mouthpiece

OR

Person who is living independently
PLUS
either suffers from severe upper extremity disability or lacks fine motor co-ordination to a degree that precludes effective inhaler techniques, even when aided by inhaler-assistance devices

OR

Resident of a long-term care facility
PLUS
regularly requires the administration of three or more inhaled medications at least three times daily

OR

Person has difficulty generating adequate inspiratory effort to achieve therapeutic benefit from an inhaler with an aerochamber

Indefinite